Markets

ZimVie Shareholders Approve Acquisition By ARCHIMED Affiliate

October 10, 2025 — 09:44 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - ZimVie Inc. (ZIMV), a life sciences company focused on the dental market, announced on Friday that its shareholders have approved the company's acquisition by an affiliate of ARCHIMED, a private equity firm.

The approval follows the merger agreement signed on July 20, 2025, under which ZimVie will be acquired for $19 per share in cash.

The acquisition is expected to close on October 20. ZimVie shares had closed at $18.97, up 0.21% on Thursday.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.